Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAMIVUDINE for Hepatitis b: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,057 adverse event reports in the FDA FAERS database where LAMIVUDINE was used for Hepatitis b.

Most Reported Side Effects for LAMIVUDINE

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 1,905 11.4% 254 229
Virologic failure 1,894 11.4% 52 80
Drug resistance 1,889 11.3% 73 220
Pathogen resistance 1,733 10.4% 26 72
Viral mutation identified 1,631 9.8% 19 51
Treatment failure 933 5.6% 97 31
Exposure during pregnancy 846 5.1% 84 91
Drug interaction 744 4.5% 174 150
Drug ineffective 726 4.4% 172 106
Immune reconstitution inflammatory syndrome 625 3.8% 88 279
Depression 594 3.6% 154 107
Treatment noncompliance 574 3.4% 30 121
Renal impairment 535 3.2% 24 117
Pyrexia 521 3.1% 132 288
Hepatitis b 480 2.9% 164 61

Other Indications for LAMIVUDINE

Hiv infection (8,963) Product used for unknown indication (2,317) Chronic hepatitis b (998) Antiretroviral therapy (848) Acquired immunodeficiency syndrome (364) Prophylaxis against hiv infection (319) Antiviral prophylaxis (299) Prophylaxis (131) Hiv test positive (97) Chronic hepatitis c (93)

Other Drugs Used for Hepatitis b

TENOFOVIR DISOPROXIL (2,088) ENTECAVIR (1,583) TENOFOVIR ALAFENAMIDE (935) ADEFOVIR DIPIVOXIL (792) EMTRICITABINE\TENOFOVIR DISOPROXIL (301) TENOFOVIR (200) PEGINTERFERON ALFA-2A (166) TELBIVUDINE (111) GLECAPREVIR\PIBRENTASVIR (98) BARACLUDE (90)

Related Pages

LAMIVUDINE Full Profile All Hepatitis b Drugs LAMIVUDINE Demographics LAMIVUDINE Timeline